Gyongyi Szabo, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver Diseases, Alcoholic | 47 | 2024 | 156 | 14.960 |
Why?
|
| Hepatitis, Alcoholic | 34 | 2024 | 109 | 14.220 |
Why?
|
| Ethanol | 68 | 2024 | 1324 | 11.760 |
Why?
|
| Inflammasomes | 23 | 2024 | 523 | 6.080 |
Why?
|
| Fatty Liver, Alcoholic | 18 | 2020 | 36 | 5.510 |
Why?
|
| MicroRNAs | 36 | 2021 | 3796 | 5.040 |
Why?
|
| Hepacivirus | 31 | 2017 | 1337 | 5.010 |
Why?
|
| Hepatocytes | 29 | 2024 | 1232 | 4.620 |
Why?
|
| Liver | 58 | 2024 | 7531 | 4.240 |
Why?
|
| Fatty Liver | 19 | 2024 | 782 | 4.190 |
Why?
|
| Monocytes | 31 | 2024 | 2572 | 3.930 |
Why?
|
| Toll-Like Receptor 4 | 28 | 2024 | 579 | 3.720 |
Why?
|
| Liver Diseases | 19 | 2024 | 1296 | 3.440 |
Why?
|
| Exosomes | 10 | 2021 | 424 | 3.190 |
Why?
|
| Interferon Regulatory Factor-3 | 6 | 2024 | 141 | 3.160 |
Why?
|
| Hepatitis | 10 | 2023 | 229 | 3.110 |
Why?
|
| Hepatitis C, Chronic | 21 | 2017 | 1032 | 2.910 |
Why?
|
| Lipopolysaccharides | 34 | 2024 | 2205 | 2.510 |
Why?
|
| Macrophages | 22 | 2024 | 5764 | 2.490 |
Why?
|
| Hepatitis C | 22 | 2015 | 1583 | 2.470 |
Why?
|
| Liver Cirrhosis | 16 | 2024 | 1934 | 2.280 |
Why?
|
| Neutrophil Infiltration | 5 | 2024 | 387 | 2.110 |
Why?
|
| Inflammation | 40 | 2024 | 10746 | 2.070 |
Why?
|
| Alcohol Drinking | 22 | 2021 | 4026 | 2.050 |
Why?
|
| Mice, Inbred C57BL | 53 | 2024 | 22121 | 2.020 |
Why?
|
| Central Nervous System Depressants | 8 | 2018 | 164 | 2.010 |
Why?
|
| Dendritic Cells | 20 | 2013 | 2725 | 1.970 |
Why?
|
| Toll-Like Receptors | 13 | 2013 | 589 | 1.790 |
Why?
|
| Interleukin-1beta | 13 | 2024 | 997 | 1.780 |
Why?
|
| Immunity, Innate | 19 | 2015 | 3059 | 1.780 |
Why?
|
| End Stage Liver Disease | 6 | 2023 | 352 | 1.710 |
Why?
|
| Alcoholism | 18 | 2024 | 1972 | 1.670 |
Why?
|
| Kupffer Cells | 13 | 2019 | 143 | 1.630 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 7 | 2024 | 299 | 1.630 |
Why?
|
| Toll-Like Receptor 2 | 15 | 2010 | 344 | 1.570 |
Why?
|
| Cholestasis | 4 | 2024 | 377 | 1.520 |
Why?
|
| Macrophage Activation | 8 | 2019 | 552 | 1.490 |
Why?
|
| Viral Core Proteins | 8 | 2008 | 161 | 1.480 |
Why?
|
| Animals | 130 | 2024 | 168253 | 1.480 |
Why?
|
| Carcinoma, Hepatocellular | 11 | 2018 | 2297 | 1.380 |
Why?
|
| Signal Transduction | 34 | 2024 | 23397 | 1.360 |
Why?
|
| Receptors, CCR2 | 3 | 2020 | 215 | 1.350 |
Why?
|
| Mice | 74 | 2024 | 81402 | 1.340 |
Why?
|
| Interferon-alpha | 10 | 2013 | 920 | 1.330 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 5 | 2023 | 617 | 1.320 |
Why?
|
| Tumor Necrosis Factor-alpha | 25 | 2016 | 4355 | 1.320 |
Why?
|
| NF-kappa B | 18 | 2022 | 2485 | 1.310 |
Why?
|
| Inflammation Mediators | 12 | 2020 | 1886 | 1.310 |
Why?
|
| Neutrophils | 6 | 2024 | 3764 | 1.310 |
Why?
|
| Liver Cirrhosis, Alcoholic | 6 | 2023 | 64 | 1.290 |
Why?
|
| Liver Neoplasms | 14 | 2018 | 4319 | 1.280 |
Why?
|
| Cytokines | 29 | 2020 | 7377 | 1.220 |
Why?
|
| Immune System | 6 | 2015 | 794 | 1.140 |
Why?
|
| Endotoxins | 5 | 2016 | 521 | 1.140 |
Why?
|
| Microglia | 3 | 2024 | 1357 | 1.130 |
Why?
|
| Interleukin-10 | 9 | 2015 | 1176 | 1.100 |
Why?
|
| Liver Neoplasms, Experimental | 3 | 2016 | 189 | 1.080 |
Why?
|
| Interleukin-1 | 5 | 2017 | 1250 | 1.050 |
Why?
|
| Myeloid Differentiation Factor 88 | 5 | 2014 | 586 | 1.040 |
Why?
|
| Myeloid Cells | 6 | 2012 | 823 | 0.990 |
Why?
|
| Acetaminophen | 6 | 2017 | 554 | 0.990 |
Why?
|
| Interferon Type I | 5 | 2013 | 562 | 0.990 |
Why?
|
| Bile Acids and Salts | 2 | 2024 | 393 | 0.960 |
Why?
|
| Viral Nonstructural Proteins | 5 | 2007 | 227 | 0.950 |
Why?
|
| Hepatic Stellate Cells | 2 | 2024 | 119 | 0.940 |
Why?
|
| HSP90 Heat-Shock Proteins | 3 | 2018 | 425 | 0.930 |
Why?
|
| Carrier Proteins | 8 | 2019 | 4936 | 0.920 |
Why?
|
| Oxazines | 2 | 2016 | 348 | 0.910 |
Why?
|
| Mice, Knockout | 24 | 2024 | 14397 | 0.910 |
Why?
|
| RNA, Viral | 6 | 2021 | 2846 | 0.890 |
Why?
|
| Liver Cirrhosis, Experimental | 2 | 2016 | 29 | 0.890 |
Why?
|
| Gene Expression Regulation | 12 | 2024 | 11900 | 0.880 |
Why?
|
| Caspase 1 | 5 | 2023 | 226 | 0.870 |
Why?
|
| Disease Models, Animal | 24 | 2024 | 18216 | 0.870 |
Why?
|
| Cell Communication | 8 | 2024 | 1652 | 0.860 |
Why?
|
| Liver Regeneration | 2 | 2017 | 213 | 0.850 |
Why?
|
| Liver Cirrhosis, Biliary | 1 | 2023 | 107 | 0.840 |
Why?
|
| Choline Deficiency | 6 | 2014 | 23 | 0.820 |
Why?
|
| Interferon-gamma | 8 | 2016 | 3157 | 0.820 |
Why?
|
| Toll-Like Receptor 7 | 2 | 2017 | 177 | 0.820 |
Why?
|
| Virus Replication | 8 | 2015 | 2435 | 0.810 |
Why?
|
| Hypoxia-Inducible Factor 1 | 2 | 2014 | 193 | 0.810 |
Why?
|
| Pentoxifylline | 1 | 2022 | 53 | 0.800 |
Why?
|
| Up-Regulation | 12 | 2016 | 4116 | 0.790 |
Why?
|
| Disease Progression | 16 | 2024 | 13484 | 0.790 |
Why?
|
| Methionine | 7 | 2015 | 572 | 0.780 |
Why?
|
| Cholangitis, Sclerosing | 1 | 2023 | 177 | 0.770 |
Why?
|
| Interleukin-13 | 1 | 2023 | 375 | 0.770 |
Why?
|
| Hepatitis, Chronic | 1 | 2021 | 52 | 0.760 |
Why?
|
| Lipid Metabolism | 7 | 2021 | 1899 | 0.760 |
Why?
|
| Humans | 181 | 2024 | 760437 | 0.750 |
Why?
|
| Nucleotidyltransferases | 1 | 2023 | 243 | 0.740 |
Why?
|
| Membrane Glycoproteins | 5 | 2019 | 3701 | 0.740 |
Why?
|
| Autophagy | 2 | 2019 | 1319 | 0.740 |
Why?
|
| Alcohols | 2 | 2014 | 94 | 0.730 |
Why?
|
| Leukocytes, Mononuclear | 6 | 2015 | 1841 | 0.710 |
Why?
|
| Acute-Phase Proteins | 2 | 2019 | 250 | 0.710 |
Why?
|
| Gastroenterology | 2 | 2021 | 577 | 0.680 |
Why?
|
| Immunity | 3 | 2020 | 997 | 0.680 |
Why?
|
| Alanine Transaminase | 7 | 2016 | 606 | 0.660 |
Why?
|
| Uric Acid | 2 | 2015 | 808 | 0.640 |
Why?
|
| Adenosine Triphosphate | 2 | 2015 | 1989 | 0.630 |
Why?
|
| Chemokine CCL2 | 7 | 2016 | 604 | 0.630 |
Why?
|
| Toll-Like Receptor 8 | 2 | 2017 | 98 | 0.630 |
Why?
|
| Receptor, Interferon alpha-beta | 2 | 2016 | 112 | 0.620 |
Why?
|
| Receptors, CCR5 | 1 | 2020 | 486 | 0.620 |
Why?
|
| Indenes | 3 | 2024 | 58 | 0.610 |
Why?
|
| Membrane Microdomains | 3 | 2013 | 206 | 0.590 |
Why?
|
| Toll-Like Receptor 9 | 4 | 2014 | 233 | 0.590 |
Why?
|
| Furans | 3 | 2024 | 200 | 0.590 |
Why?
|
| CARD Signaling Adaptor Proteins | 4 | 2023 | 158 | 0.590 |
Why?
|
| Multiple Organ Failure | 1 | 2020 | 386 | 0.590 |
Why?
|
| Cytoskeletal Proteins | 2 | 2013 | 1341 | 0.580 |
Why?
|
| Phosphorylation | 10 | 2024 | 8311 | 0.580 |
Why?
|
| Research | 4 | 2021 | 1977 | 0.570 |
Why?
|
| Vimentin | 2 | 2015 | 255 | 0.560 |
Why?
|
| Receptors, Cell Surface | 5 | 2015 | 2819 | 0.550 |
Why?
|
| Cells, Cultured | 17 | 2024 | 18955 | 0.540 |
Why?
|
| Killer Cells, Natural | 6 | 2015 | 2202 | 0.540 |
Why?
|
| Sulfones | 3 | 2024 | 447 | 0.530 |
Why?
|
| Lymphocyte Antigen 96 | 3 | 2011 | 21 | 0.520 |
Why?
|
| Female | 84 | 2024 | 391875 | 0.520 |
Why?
|
| Blotting, Western | 9 | 2017 | 5031 | 0.510 |
Why?
|
| Hepatitis C Antibodies | 2 | 2012 | 146 | 0.510 |
Why?
|
| Probenecid | 1 | 2015 | 73 | 0.510 |
Why?
|
| Granuloma | 2 | 2008 | 327 | 0.500 |
Why?
|
| Phagocytosis | 2 | 2018 | 1536 | 0.490 |
Why?
|
| Sarcopenia | 1 | 2020 | 372 | 0.490 |
Why?
|
| Receptors, Interleukin-1 | 3 | 2022 | 262 | 0.480 |
Why?
|
| Encephalitis | 1 | 2018 | 438 | 0.480 |
Why?
|
| Reactive Oxygen Species | 6 | 2022 | 2137 | 0.480 |
Why?
|
| Membrane Proteins | 4 | 2016 | 7849 | 0.480 |
Why?
|
| Gastrointestinal Tract | 2 | 2011 | 831 | 0.470 |
Why?
|
| Pyridines | 2 | 2016 | 2868 | 0.460 |
Why?
|
| Cell Differentiation | 9 | 2017 | 11526 | 0.460 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 8 | 2019 | 3800 | 0.460 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2019 | 390 | 0.450 |
Why?
|
| RNA, Ribosomal, 16S | 2 | 2017 | 1037 | 0.450 |
Why?
|
| RNA, Messenger | 13 | 2022 | 12785 | 0.450 |
Why?
|
| Allopurinol | 1 | 2015 | 198 | 0.450 |
Why?
|
| Intestines | 4 | 2018 | 1909 | 0.450 |
Why?
|
| Lysosomes | 1 | 2019 | 919 | 0.450 |
Why?
|
| Cell Death | 3 | 2021 | 1664 | 0.450 |
Why?
|
| Anti-Infective Agents, Local | 2 | 2013 | 247 | 0.440 |
Why?
|
| Neutralization Tests | 2 | 2014 | 728 | 0.440 |
Why?
|
| STAT3 Transcription Factor | 2 | 2008 | 870 | 0.440 |
Why?
|
| RNA, Neoplasm | 1 | 2016 | 749 | 0.430 |
Why?
|
| Cyclin G1 | 1 | 2012 | 15 | 0.430 |
Why?
|
| Antigens, CD | 2 | 2024 | 4000 | 0.420 |
Why?
|
| Antigen-Presenting Cells | 3 | 2008 | 964 | 0.420 |
Why?
|
| Sulfoxides | 2 | 2024 | 47 | 0.420 |
Why?
|
| RNA Stability | 2 | 2015 | 331 | 0.420 |
Why?
|
| Pancreatitis, Alcoholic | 2 | 2015 | 28 | 0.410 |
Why?
|
| Histone Deacetylases | 1 | 2017 | 719 | 0.410 |
Why?
|
| Apoptosis | 10 | 2023 | 9468 | 0.410 |
Why?
|
| Probiotics | 2 | 2023 | 378 | 0.410 |
Why?
|
| Cell Polarity | 1 | 2015 | 637 | 0.400 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 2 | 2009 | 76 | 0.390 |
Why?
|
| Transcription Factors | 6 | 2017 | 12121 | 0.390 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 4 | 2023 | 140 | 0.380 |
Why?
|
| DNA-Binding Proteins | 4 | 2017 | 9598 | 0.380 |
Why?
|
| Reperfusion Injury | 2 | 2015 | 1023 | 0.370 |
Why?
|
| Male | 54 | 2024 | 360035 | 0.370 |
Why?
|
| Cell Proliferation | 6 | 2022 | 10425 | 0.370 |
Why?
|
| Poly I-C | 1 | 2011 | 112 | 0.370 |
Why?
|
| Interleukins | 2 | 2012 | 782 | 0.370 |
Why?
|
| Interleukin-12 | 2 | 2004 | 583 | 0.370 |
Why?
|
| National Institute on Alcohol Abuse and Alcoholism (U.S.) | 1 | 2010 | 10 | 0.360 |
Why?
|
| Metabolome | 1 | 2017 | 986 | 0.350 |
Why?
|
| Toll-Like Receptor 1 | 2 | 2007 | 47 | 0.350 |
Why?
|
| Brain | 5 | 2020 | 27060 | 0.340 |
Why?
|
| alpha-Fetoproteins | 2 | 2023 | 223 | 0.340 |
Why?
|
| Case-Control Studies | 11 | 2020 | 22097 | 0.340 |
Why?
|
| Interleukin-6 | 7 | 2023 | 3209 | 0.340 |
Why?
|
| RNA, Double-Stranded | 1 | 2011 | 295 | 0.340 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 4 | 2022 | 61 | 0.330 |
Why?
|
| Electrophoretic Mobility Shift Assay | 4 | 2014 | 293 | 0.330 |
Why?
|
| Immunocompromised Host | 1 | 2015 | 855 | 0.330 |
Why?
|
| Sex Characteristics | 1 | 2020 | 2633 | 0.330 |
Why?
|
| DNA, Bacterial | 1 | 2014 | 1481 | 0.320 |
Why?
|
| Sepsis | 3 | 2018 | 2583 | 0.320 |
Why?
|
| Sulfonamides | 3 | 2024 | 1973 | 0.320 |
Why?
|
| Propionibacterium acnes | 2 | 2008 | 65 | 0.320 |
Why?
|
| Hepatitis B, Chronic | 1 | 2013 | 410 | 0.320 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 6 | 2017 | 4567 | 0.320 |
Why?
|
| Immunity, Cellular | 3 | 2012 | 1559 | 0.310 |
Why?
|
| Transcription Factor RelA | 2 | 2007 | 253 | 0.310 |
Why?
|
| RNA-Binding Proteins | 2 | 2019 | 1897 | 0.310 |
Why?
|
| Autoantigens | 1 | 2013 | 876 | 0.310 |
Why?
|
| DNA Virus Infections | 1 | 2008 | 15 | 0.300 |
Why?
|
| RNA Virus Infections | 1 | 2008 | 19 | 0.300 |
Why?
|
| Microfilament Proteins | 1 | 2013 | 1134 | 0.300 |
Why?
|
| Toll-Like Receptor 6 | 1 | 2007 | 28 | 0.290 |
Why?
|
| Statistics, Nonparametric | 5 | 2014 | 2852 | 0.290 |
Why?
|
| Gene Expression | 5 | 2017 | 7582 | 0.290 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2008 | 178 | 0.290 |
Why?
|
| Metagenome | 1 | 2011 | 450 | 0.290 |
Why?
|
| Adaptor Proteins, Signal Transducing | 4 | 2012 | 2895 | 0.290 |
Why?
|
| Fibrosis | 3 | 2021 | 2048 | 0.280 |
Why?
|
| STAT1 Transcription Factor | 1 | 2008 | 340 | 0.280 |
Why?
|
| Sp1 Transcription Factor | 1 | 2007 | 140 | 0.280 |
Why?
|
| Age Factors | 1 | 2023 | 18379 | 0.280 |
Why?
|
| T-Lymphocytes, Regulatory | 3 | 2012 | 3072 | 0.280 |
Why?
|
| Intestinal Mucosa | 2 | 2014 | 3026 | 0.270 |
Why?
|
| Liver Transplantation | 6 | 2021 | 2332 | 0.270 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2007 | 687 | 0.270 |
Why?
|
| Severity of Illness Index | 9 | 2023 | 15820 | 0.270 |
Why?
|
| Carbon Tetrachloride | 2 | 2016 | 72 | 0.270 |
Why?
|
| Science | 1 | 2009 | 239 | 0.260 |
Why?
|
| Propionibacterium | 1 | 2005 | 4 | 0.260 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2013 | 1766 | 0.260 |
Why?
|
| Cell Line | 8 | 2015 | 15598 | 0.260 |
Why?
|
| CHO Cells | 5 | 2007 | 1389 | 0.260 |
Why?
|
| Bacteria | 4 | 2022 | 2217 | 0.260 |
Why?
|
| Cerebellum | 1 | 2013 | 1500 | 0.260 |
Why?
|
| I-kappa B Kinase | 1 | 2007 | 250 | 0.260 |
Why?
|
| Forkhead Transcription Factors | 1 | 2013 | 1611 | 0.260 |
Why?
|
| Transcription Factor AP-1 | 1 | 2007 | 321 | 0.260 |
Why?
|
| Gene Silencing | 1 | 2012 | 1509 | 0.250 |
Why?
|
| NF-kappa B p50 Subunit | 2 | 2022 | 103 | 0.250 |
Why?
|
| Receptors, Pattern Recognition | 1 | 2006 | 83 | 0.250 |
Why?
|
| Oxidative Stress | 6 | 2022 | 3108 | 0.250 |
Why?
|
| Bone Marrow Cells | 2 | 2014 | 2416 | 0.250 |
Why?
|
| Clinical Trials as Topic | 3 | 2019 | 7996 | 0.250 |
Why?
|
| Liver Function Tests | 4 | 2019 | 522 | 0.250 |
Why?
|
| Diet | 5 | 2024 | 8058 | 0.250 |
Why?
|
| I-kappa B Proteins | 2 | 2002 | 211 | 0.250 |
Why?
|
| Research Design | 3 | 2017 | 6168 | 0.250 |
Why?
|
| Interleukin-1alpha | 2 | 2017 | 86 | 0.250 |
Why?
|
| Cricetinae | 5 | 2007 | 2427 | 0.240 |
Why?
|
| Antibody Formation | 2 | 2006 | 1397 | 0.240 |
Why?
|
| T-Lymphocytes | 5 | 2008 | 10188 | 0.240 |
Why?
|
| Immune Tolerance | 2 | 2012 | 2300 | 0.240 |
Why?
|
| Antibodies, Neutralizing | 1 | 2014 | 1942 | 0.240 |
Why?
|
| Triglycerides | 4 | 2014 | 2458 | 0.240 |
Why?
|
| Receptors, Immunologic | 3 | 2007 | 1411 | 0.240 |
Why?
|
| HMGB1 Protein | 2 | 2018 | 137 | 0.240 |
Why?
|
| src-Family Kinases | 1 | 2007 | 535 | 0.240 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2012 | 2821 | 0.240 |
Why?
|
| Adult | 34 | 2024 | 220781 | 0.240 |
Why?
|
| Isoantigens | 2 | 2004 | 552 | 0.230 |
Why?
|
| Polymorphism, Genetic | 1 | 2014 | 4287 | 0.230 |
Why?
|
| Ligands | 5 | 2012 | 3270 | 0.230 |
Why?
|
| Down-Regulation | 4 | 2018 | 2911 | 0.230 |
Why?
|
| Heme Oxygenase-1 | 1 | 2006 | 365 | 0.230 |
Why?
|
| Clonal Anergy | 1 | 2004 | 171 | 0.230 |
Why?
|
| Receptors, Glucocorticoid | 2 | 2002 | 303 | 0.230 |
Why?
|
| Middle Aged | 34 | 2024 | 220382 | 0.230 |
Why?
|
| Amino Acids, Aromatic | 1 | 2023 | 36 | 0.220 |
Why?
|
| Neoplasm Proteins | 1 | 2016 | 3610 | 0.220 |
Why?
|
| Gene Expression Profiling | 4 | 2015 | 9410 | 0.220 |
Why?
|
| Complement System Proteins | 2 | 2024 | 788 | 0.220 |
Why?
|
| Antigens, Ly | 1 | 2004 | 294 | 0.220 |
Why?
|
| Fatty Acids | 1 | 2011 | 1805 | 0.220 |
Why?
|
| Cytochrome P-450 CYP2E1 | 2 | 2016 | 35 | 0.220 |
Why?
|
| Energy Metabolism | 2 | 2023 | 2875 | 0.220 |
Why?
|
| Interferons | 3 | 2012 | 704 | 0.220 |
Why?
|
| Time Factors | 9 | 2018 | 39947 | 0.210 |
Why?
|
| Prognosis | 10 | 2024 | 29551 | 0.210 |
Why?
|
| Alzheimer Disease | 1 | 2024 | 8579 | 0.210 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2005 | 343 | 0.210 |
Why?
|
| Coenzyme A Ligases | 1 | 2022 | 45 | 0.210 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2004 | 856 | 0.210 |
Why?
|
| Granulocytes | 1 | 2024 | 550 | 0.200 |
Why?
|
| Gene Knockdown Techniques | 2 | 2017 | 1610 | 0.200 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2023 | 256 | 0.200 |
Why?
|
| Antiviral Agents | 6 | 2012 | 3066 | 0.200 |
Why?
|
| Bile Ducts | 1 | 2023 | 282 | 0.200 |
Why?
|
| Growth Inhibitors | 1 | 2003 | 378 | 0.200 |
Why?
|
| Zinc | 2 | 2024 | 689 | 0.190 |
Why?
|
| Immunoprecipitation | 2 | 2014 | 877 | 0.190 |
Why?
|
| Chronic Disease | 5 | 2024 | 9309 | 0.190 |
Why?
|
| Autoimmunity | 1 | 2009 | 1355 | 0.180 |
Why?
|
| Permeability | 2 | 2014 | 721 | 0.180 |
Why?
|
| Methylamines | 1 | 2022 | 137 | 0.180 |
Why?
|
| Kidney | 4 | 2023 | 7046 | 0.180 |
Why?
|
|